National Institutes of Health (NIH) is one of the world’s foremost medical research centers. An agency of the U.S. Department of Health and Human Services is the nation’s medical research agency making important discoveries that improve health and save lives (https://www.nih.gov/). Dr Udayan Guha is the investigator at Thoracic, GI Malignancies Branch & head of Cancer Signaling Networks Section which is located in Building 10 at National Cancer Institute, NIH, Bethesda, MD, USA (https://ccr.cancer.gov/thoracic-and-gi-malignancies-branch/udayan-guha). Dr Guha’s group has state-of-the-art tumorigenesis, a quantitative mass spectrometry facility aimed at clarify the perturbed-signaling pathways that cause tumorigenesis and developing immunopeptidomics to identify direct therapeutic implications, strategies for the treatment of human cancer. I am developing a collaboration between the University of Gdańsk and NCI/NIH aimed at developing new methods for immunopeptidomics which is part of the research project concerning the neoantigen discovery pipeline.
Sachin Kote (June 2019)